XML 150 R39.htm IDEA: XBRL DOCUMENT v3.24.0.1
Collaboration and License Agreements - Visirna Therapeutics, Inc. (Details) - USD ($)
3 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Sep. 30, 2023
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]      
Revenue $ 3,551,000 $ 62,546,000  
Deferred revenue 0   $ 866,000
Visirna Therapeutics, Inc. | Visirna License Agreement      
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]      
Revenue 85,989 $ 749,262  
Contract assets 0    
Deferred revenue $ 0